BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 22000584)

  • 1. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
    Davids M; Richir MC; Visser M; Ellger B; van den Berghe G; van Leeuwen PA; Teerlink T
    Metabolism; 2012 Apr; 61(4):482-90. PubMed ID: 22000584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity.
    Ellger B; Richir MC; van Leeuwen PA; Debaveye Y; Langouche L; Vanhorebeek I; Teerlink T; Van den Berghe G
    Endocrinology; 2008 Jun; 149(6):3148-57. PubMed ID: 18292189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
    Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S
    J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver plays a central role in asymmetric dimethylarginine-mediated organ injury.
    Ferrigno A; Di Pasqua LG; Berardo C; Richelmi P; Vairetti M
    World J Gastroenterol; 2015 May; 21(17):5131-7. PubMed ID: 25954086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
    Desai A; Zhao Y; Warren JS
    Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADMA metabolism and clearance.
    Teerlink T
    Vasc Med; 2005 Jul; 10 Suppl 1():S73-81. PubMed ID: 16444872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.
    Anderssohn M; Maass LM; Diemert A; Lüneburg N; Atzler D; Hecher K; Böger RH
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):152-6. PubMed ID: 22285683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
    Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
    JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue.
    Maas R; Tan-Andreesen J; Schwedhelm E; Schulze F; Böger RH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 851(1-2):220-8. PubMed ID: 17296339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
    Matsumoto Y; Ueda S; Yamagishi S; Matsuguma K; Shibata R; Fukami K; Matsuoka H; Imaizumi T; Okuda S
    J Am Soc Nephrol; 2007 May; 18(5):1525-33. PubMed ID: 17409314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO.
    Wang D; Gill PS; Chabrashvili T; Onozato ML; Raggio J; Mendonca M; Dennehy K; Li M; Modlinger P; Leiper J; Vallance P; Adler O; Leone A; Tojo A; Welch WJ; Wilcox CS
    Circ Res; 2007 Sep; 101(6):627-35. PubMed ID: 17673667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine.
    Li J; Wilson A; Gao X; Kuruba R; Liu Y; Poloyac S; Pitt B; Xie W; Li S
    J Pharmacol Exp Ther; 2009 Oct; 331(1):234-43. PubMed ID: 19605523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
    Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
    Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans.
    Chobanyan K; Thum T; Suchy MT; Zhu B; Mitschke A; Gutzki FM; Beckmann B; Stichtenoth DO; Tsikas D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):32-41. PubMed ID: 17825631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease.
    Tanaka M; Sydow K; Gunawan F; Jacobi J; Tsao PS; Robbins RC; Cooke JP
    Circulation; 2005 Sep; 112(11):1549-56. PubMed ID: 16144995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
    Davids M; Teerlink T
    Metabolism; 2013 Oct; 62(10):1455-61. PubMed ID: 23890667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
    Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y
    Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.